Details for New Drug Application (NDA): 079217
✉ Email this page to a colleague
NDA 079217 describes DRONABINOL, which is a drug marketed by Ascent Pharms Inc, Hikma, Insys Therap, Lannett Co Inc, and Rhodes, and is included in five NDAs. It is available from one supplier. Additional details are available on the DRONABINOL profile page.
The generic ingredient in DRONABINOL is dronabinol. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
The generic ingredient in DRONABINOL is dronabinol. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
Summary for 079217
| Tradename: | DRONABINOL |
| Applicant: | Hikma |
| Ingredient: | dronabinol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 079217
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Jun 20, 2014 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
| Approval Date: | Jun 20, 2014 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jun 20, 2014 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
